Valuation: ALTEOGEN Inc.

Market Cap 11,725B 8.72B 7.78B 7.16B 6.5B 12.31B 817B 12.62B 85.64B 34.13B 437B 32.71B 32.01B 1,378B P/E 2026 *
39x
P/E 2027 * 31.3x
Enterprise Value 11.23B 8.35M 7.45M 6.86M 6.22M 11.79M 783M 12.09M 82.03M 32.7M 419M 31.34M 30.67M 1.32B EV / Sales 2026 *
24.1x
EV / Sales 2027 * 17x
Free-Float
74.44%
Yield 2026 *
0.25%
Yield 2027 * 0.31%
1 day-16.01%
1 week-20.38%
Current month-20.38%
1 month-30.12%
3 months-44.79%
6 months-35.71%
Current year-51.30%
1 week 152,500
Extreme 152500.00000000
224,000
1 month 152,500
Extreme 152500.00000000
243,500
Current year 152,500
Extreme 152500.00000000
406,923.08
1 year 152,500
Extreme 152500.00000000
437,692.31
3 years 46,846.15
Extreme 46846.153846
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
21/05/25 Exercice

Chief Executive Officer

7,200 0.0135%
27/03/24 Sell 1,600,000 3.0182%
05/01/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-16.01%-20.38%-58.54%+234.23% 10.24B
+4.28%-0.39%+52.75%+128.05% 1,206B
+2.13%+3.26%+51.21%+87.64% 665B
+0.68%-0.54%+33.83%+106.51% 515B
+2.77%-0.57%+49.44%+68.42% 381B
+1.38%-0.51%+72.42%+42.49% 362B
+0.29%-0.24%+30.84%+57.23% 307B
+0.98%+0.76%+9.04%+38.31% 289B
+1.04%-0.17%+45.29%+70.25% 249B
+1.46%-0.80%+42.48%+117.36% 207B
Average -1.09%-3.50%+32.88%+95.05% 419B
Weighted average by Cap. +0.23%-2.00%+45.74%+91.12%

Financials

2026 *2027 *
Net sales 466B 347M 309M 285M 258M 490M 32.49B 502M 3.41B 1.36B 17.4B 1.3B 1.27B 54.79B 647B 481M 429M 395M 358M 679M 45.05B 696M 4.72B 1.88B 24.12B 1.8B 1.77B 75.96B
Net income 283B 210M 188M 173M 157M 297M 19.72B 305M 2.07B 824M 10.56B 790M 773M 33.25B 370B 275M 245M 226M 205M 388M 25.75B 398M 2.7B 1.08B 13.79B 1.03B 1.01B 43.42B
Net Debt -494B -367M -327M -301M -273M -518M -34.39B -531M -3.6B -1.44B -18.41B -1.38B -1.35B -57.98B -728B -541M -483M -445M -404M -765M -50.74B -784M -5.32B -2.12B -27.17B -2.03B -1.99B -85.56B
Projected Income Statement - Annual - ALTEOGEN Inc.
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
09/11/26 ₩168,400.00 -16.01% 2,807,483
06/11/26 ₩200,500.00 -5.20% 447,539
05/11/26 ₩211,500.00 +3.68% 518,623
04/11/26 ₩204,000.00 -4.45% 753,371
03/11/26 ₩213,500.00 +0.23% 289,568
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - ALTEOGEN Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
168,400.00KRW
Average target price
373,333.33KRW
Spread / Average Target
+121.69%
  1. Stock Market
  2. Stocks
  3. A196170 Stock